Zur Kurzanzeige

Long-term seizure outcome after epilepsy surgery of neuroglial tumors

dc.contributor.authorRácz, Attila
dc.contributor.authorMüller, Philipp
dc.contributor.authorBecker, Albert
dc.contributor.authorHoffmann, Nico
dc.contributor.authorRüber, Theodor
dc.contributor.authorBorger, Valeri
dc.contributor.authorVatter, Hartmut
dc.contributor.authorSurges, Rainer
dc.contributor.authorElger, Christian E.
dc.date.accessioned2025-07-22T11:39:32Z
dc.date.available2025-07-22T11:39:32Z
dc.date.issued23.05.2024
dc.identifier.urihttps://hdl.handle.net/20.500.11811/13253
dc.description.abstractPurpose: Neuroglial tumors are frequently associated with pharmacorefractory epilepsies. However, comprehensive knowledge about long-term outcomes after epilepsy surgery and the main prognostic factors for outcome is still limited. We sought to evaluate long-term outcomes and potential influencing factors in a large cohort of patients who underwent surgery for neuroglial tumors in a single-center setting.
Methods: The study analyzed the outcomes of 107 patients who underwent epilepsy surgery for neuroglial tumors between 2001 and 2020 at the Department of Epileptology, University Hospital Bonn, in Germany. The outcomes were evaluated using Engel classification. Differences in outcome related to potential prognostic factors were examined using the Chi2-test, Fisher's exact test and sign test. Additionally, stepwise logistic regression analysis was employed to identify independent prognostic factors.
Results: Complete seizure freedom (Engel Class IA) was achieved in 75% of the operated patients at 12 months, and 56% at the last follow-up visit (70.4 ± 6.2 months, median: 40 months). Completeness of resection was a crucial factor for both 12-month follow-up outcomes and the longest available outcomes, whereas lobar tumor localization, histology (ganglioglioma vs. dysembryoplastic neuroepithelial tumor), history of bilateral tonic–clonic seizures prior to surgery, invasive diagnostics, side of surgery (dominant vs. non-dominant hemisphere), age at epilepsy onset, age at surgery, and epilepsy duration did not consistently impact postsurgical outcomes. Among temporal lobe surgeries, patients who underwent lesionectomy and lesionectomy, including hippocampal resection, demonstrated similar outcomes.
Conclusion: Neuroglial tumors present as excellent surgical substrates in treating structural epilepsy. To achieve an optimal postsurgical outcome, a complete lesion resection should be pursued whenever possible.
en
dc.format.extent11
dc.language.isoeng
dc.rightsNamensnennung 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectneuroglial tumor
dc.subjectganglioglioma
dc.subjectdysembryoplastic neuroepithelial tumor
dc.subjectDNET
dc.subjectepilepsy surgery
dc.subjectoutcome
dc.subjecthippocampal sclerosis (HS)
dc.subject.ddc610 Medizin, Gesundheit
dc.titleLong-term seizure outcome after epilepsy surgery of neuroglial tumors
dc.typeWissenschaftlicher Artikel
dc.publisher.nameFrontiers Media SA
dc.publisher.locationLausanne
dc.rights.accessRightsopenAccess
dcterms.bibliographicCitation.volume2024, vol. 15
dcterms.bibliographicCitation.issue1384494
dcterms.bibliographicCitation.pagestart1
dcterms.bibliographicCitation.pageend11
dc.relation.doihttps://doi.org/10.3389/fneur.2024.1384494
dcterms.bibliographicCitation.journaltitleFrontiers in neurology
ulbbn.pubtypeZweitveröffentlichung
dc.versionpublishedVersion
ulbbn.sponsorship.oaUnifundOA-Förderung Universität Bonn


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Die folgenden Nutzungsbestimmungen sind mit dieser Ressource verbunden:

Namensnennung 4.0 International